Supplementary Table 1: Cutaneous adverse events associated with MEK-inhibitors for the treatment of vascular anomalies: a multicenter retrospective study

Supplementary Table 1: Most common cutaneous adverse events observed in patients with vascular anomalies taking MEK-inhibitors, excluding patients on concurrent therapies.补充表1：接受MEK抑制剂（MEK-inhibitors）治疗的血管异常患者中观察到的最常见皮肤不良事件（排除同时接受合并治疗的患者）